Visitors and news

Breast cancer is the most common cancer among women worldwide, impacting 2.1 million women each year. Early detection through screening helps improve survival rates.
View the WHO Breast cancer page to learn more about the current WHO recommandations.

This webinar will showcase examples of global cancer research partnerships and collaborations from the US National Cancer Institute (NCI) perspective. Dr Partha Basu, Head, Screening Group will be delighted to present the role of collaborative research to identify effective and affordable technologies and inform global policies in cancer prevention.
View the NCI at London Global Cancer Week 2020 page

Dr Partha Basu, Head of Screening Group, Early Detection & Prevention Section at the International Agency for Research on Cancer invites you to join the virtual European Cancer Summit 2020 session on Prevention between 18 to 19 November 2020.
View the video.

Throughout October, the International Agency for Research on Cancer (IARC) will mark Breast Cancer Awareness Month with a series of posts, including tweets, interviews, and infographics. Stay tuned to the IARC website, www.iarc.fr, the IARC Twitter account, @IARCWHO, and the IARC YouTube channel, IARC WHO, during October to learn more about Breast cancer. Read the IARC news

Noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 71% of all deaths globally. NCDs, also known as chronic diseases, tend to be of long duration and are the result of a combination of genetic, physiological, environmental and behavioural factors. The main types of NCDs are cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. An integrated approach is particularly important for low-resource settings for efficient use of limited resources. WHO Package of Essential NCD interventions will help to improve the coverage of appropriate services for people with NCDs services in primary care settings. View the WHO publication.

In this study, the authors evaluated the efficacy of thermal ablation in treatment of CIN detected through high-risk HPV screening in China. They found that thermal ablation is effective to treat CIN as well as to clear the high-risk HPV infection. HPV test could be a suitable surveillance test for women following treatment. This point-of-care ablative technique improves the access to treatment of cervical premalignant lesions in LMICs.
View the article

Dr Partha Basu, head of the screening group, supports the new academic initiative of Indian College of Obstetricians & Gynaecologists (ICOG) and will participate to the inauguration of the Journal club on 9th September 2020 at 5pm Indian time.
Free registration

Ms Lara Rodrigues Da Matta Calegari from the Faculdade Evangélica Mackenzie do Paraná, Brazil, has joined the Screening Group at IARC as an intern. Lara will participate in research activities on health inequalities research related to cancer screening programmes, evaluating data on measurable indicators of inequalities in access to screening in low and middle income countries.

In this commentary published in HPVWORLD, Dr Partha Basu discusses the Quebec's Mixed HPV vaccination schedule introduction: The revised vaccination schedule has allowed the Quebec Government to save $ 3 million a year that they have utilized to extend the vaccination to the boys in Grade 4 of primary school. View the commentary.

Ms Thea Beate Brevik from Molde University College, Norway, has joined the Screening Group at IARC as a postdoctoral fellow. Thea will participate in research activities on the health inequalities research related to cancer screening programmes, evaluating data on measurable indicators of education and cancer screening participation, as well as inequalities in access to screening (barriers).